🇺🇸 FDA

Intelligence Platform

Patents

Browse 57 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9867873

Factor IX polypeptides and methods of use thereof

BIOVERATIV THERAPEUTICS INC. · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9856468

Processable single chain molecules and polypeptides made using same

BIOVERATIV THERAPEUTICS INC. · Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9725496

Immunoglobulin chimeric monomer-dimer hybrids

BIOVERATIV THERAPEUTICS INC. · Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9675676

Factor IX polypeptides and methods of use thereof

BIOVERATIV THERAPEUTICS INC. · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9670475

Factor IX polypeptides and methods of use thereof

BIOVERATIV THERAPEUTICS INC. · Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9636416

Immunoglobulin chimeric monomer-dimer hybrids

BIOVERATIV THERAPEUTICS INC. · Granted Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9629903

Factor IX polypeptides and methods of use thereof

BIOVERATIV THERAPEUTICS INC. · Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9623091

Factor IX polypeptides and methods of use thereof

BIOVERATIV THERAPEUTICS INC. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9623088

Factor VIII polypeptide formulations

BIOVERATIV THERAPEUTICS INC. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted